Stonnington Group, LLC Reata Pharmaceuticals Inc Transaction History
Stonnington Group, LLC
- $381 Million
- Q1 2023
A detailed history of Stonnington Group, LLC transactions in Reata Pharmaceuticals Inc stock. As of the latest transaction made, Stonnington Group, LLC holds 10,100 shares of RETA stock, worth $0. This represents 0.24% of its overall portfolio holdings.
Number of Shares
10,100Holding current value
$0% of portfolio
0.24%Shares
1 transactions
Others Institutions Holding RETA
# of Institutions
5Shares Held
62.7KCall Options Held
0Put Options Held
0About REATA PHARMACEUTICALS INC
- Ticker RETA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,583,200
- Description
- Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...